Frontage Laboratories completes acquisition of Teddy Lab to strengthen global central laboratory capabilities

Join Pharma | Login

	Editorial


	DEFINITION ON OTC DRUGS
	Wednesday, March 4, 2026
	A robust regulatory framework for over-the-counter (OTC) medicines has been long overdue in the country. It is almost nine years since the Union Health Ministry constituted a subcommittee on the issue.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Frontage Laboratories completes acquisition of Teddy Lab to strengthen global central laboratory capabilities
17:00 [IST]	Hopewell Therapeutics sublicenses its proprietary lipid nanoparticles for novel cancer vaccine to Foxcroft Therapeutics
16:30 [IST]	Board of directors of Sanofi to propose appointment of Christel Heydemann as an independent director at next AGM
16:00 [IST]	NIHR awards £50 million for vital NHS research equipment
15:00 [IST]	Lifecore Biomedical signs service agreement with Indomo to develop corticosteroid drug candidate, DT-001
14:00 [IST]	Biologos appoints Hetal Patel as chief executive officer

more news >>

TOP NEWS


08:00 [IST]	AIOCD opposes govt move to grant drug licenses to PACS citing grave risks to public health
08:00 [IST]	Imports of bulk drugs and intermediates decline 9.3% in January
08:00 [IST]	Experts see need for inclusive policy framework & insurance coverage for multiple sclerosis & haemophilia
08:00 [IST]	CRSIC e-Symposium showcases cutting-edge innovations & translational advances shaping the future of controlled release
08:00 [IST]	Karnataka govt gives a booster shot to healthcare by allocating Rs.17,473.4 crore
08:00 [IST]	IPC to hold scientific conference on strengthening blood transfusion services on March 11

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Altruist Biologics introduces Altru-CON, a high-concentration formulation platform to speed up biologics development
17:30 [IST]	ASG Eye Hospital launches advanced ocular oncology services
17:15 [IST]	CM Yogi Adityanath inaugurates KDSG Super Speciality Hospital in Greater Noida, operated by Ajeenkya DY Patil Healthcare
16:30 [IST]	Alembic Pharma announces first prescription sale of Pivya following US commercial launch
17:40 [IST]	Apollo Hospitals, Hyderabad clinical study notes robotic myomectomy to safeguard fertility and reproductive choices
17:20 [IST]	Cetaphil raises the bar with its innovation, ‘Healthy Renew’ range in India targeted at anti-aging solution seekers

more news >>

INTERVIEW


Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana

Past Interviews...

	What's New?

iguratimod 25 mg tablet nebivolol 5 mg +telmisartan 40 mg tab hydroxyzine 25 mg oint methyl salicylate 450 gm clindamycin 100 mg + clotrimazole 200 mg etc...

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers